IOL for reducing secondary opacification
AssigneeAdvanced Medical Optics, Inc.
InventorsCraig Young, Glenn R. Sussman, Crystal M. Cunanan
Life of this patent
Estimating the term…
Abstract
An IOL implantable in an eye comprising an optic having an optical portion for directing light toward the retina of the eye and a cell barrier portion for inhibiting cell growth from the eye in front of or in back of the optical portion. The cell barrier portion circumscribes the optical portion, is incapable of focusing light on the retina and includes an irregularly configured structure, for example, irregular grooves. At least one elongated fixation member is coupled to the optic for use in fixing the optic in the eye.
Claims7
An intraocular lens implantable in an eye comprising:
- an optical portion adapted for placement in a capsular bag of the eye and for directing light toward the retina of the eye;
- and
- a cell barrier portion circumscribing said optical portion, and the optical portion and the cell barrier portion being made of the same material, wherein the cell barrier portion includes at least about 20 annular grooves and is structured to be white when viewed by a naked eye;
- and
- at least one elongated fixation member coupled to the optical portion or the cell barrier portion and extending radially outwardly of the optical portion and the cell barrier portion for fixing the intraocular lens in the eye.
An intraocular lens implantable in an eye comprising:
- an optical portion adapted for placement in a capsular bag of the eye and for directing light toward the retina of the eye;
- and
- a cell barrier portion made of a polymeric material, circumscribing said optical portion, the cell barrier portion including at least about 20 annular grooves, and being white when viewed by a naked eye.
An intraocular lens implantable in an eye comprising:
- an optical portion adapted for placement in a capsular bag of the eye and for directing light toward the retina of the eye;
- and
- a cell barrier portion circumscribing said optical portion, wherein the cell barrier portion is effective to inhibit growth or migration of cells from the eye in back of the optical portion and is structured to be white when viewed by a naked eye.
Dependencies are inferred from the claim text.